Integer Corporation
138.55
3.40 (2.52%)
At close: Jan 14, 2025, 3:59 PM
138.83
0.20%
After-hours Jan 14, 2025, 04:10 PM EST

Integer Corporation Revenue Breakdown

Quarter Sep 27, 2024Sep 30, 2016Jul 1, 2016Apr 1, 2016
Advanced Surgical, Orthopedics, and Portable Medical Revenue 25.31M 95.19M 104.32M 91.33M
Advanced Surgical, Orthopedics, and Portable Medical Revenue Growth -73.41% -8.75% +14.22% n/a
Cardio And Vascular Revenue 241.01M 148.27M 144.22M 133.65M
Cardio And Vascular Revenue Growth +62.54% +2.81% +7.91% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 28, 2018Dec 29, 2017Dec 30, 2016Jan 1, 2016Jan 2, 2015Jan 3, 2014Dec 28, 2012
Puerto Rico Revenue 108.42M 114.08M 110.16M 96.05M 154.64M 146.50M 133.75M 159.24M 136.90M 127.70M 117.96M 105.73M
Puerto Rico Revenue Growth -4.96% +3.55% +14.69% -37.89% +5.56% +9.53% -16.01% +16.32% +7.20% +8.26% +11.57% n/a
Rest Of World Revenue 501.25M 423.74M 372.44M 321.74M 341.34M 319.21M 465.88M 352.64M 199.59M 182.24M 113.77M 107.93M
Rest Of World Revenue Growth +18.29% +13.78% +15.76% -5.74% +6.93% -31.48% +32.11% +76.68% +9.52% +60.19% +5.41% n/a
United States Revenue 897.43M 762.13M 671.50M 596.80M 698.47M 687.26M 862.29M 805.74M 401.38M 312.54M 325.09M n/a
United States Revenue Growth +17.75% +13.50% +12.52% -14.56% +1.63% -20.30% +7.02% +100.74% +28.43% -3.86% n/a n/a

Operating Expense Breakdown

Quarter Sep 27, 2024Jun 28, 2024Mar 29, 2024Dec 31, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Apr 1, 2022Dec 31, 2021Oct 1, 2021Jul 2, 2021Apr 2, 2021Dec 31, 2020Oct 2, 2020Jul 3, 2020Apr 3, 2020Dec 31, 2019Sep 27, 2019Jun 28, 2019Mar 29, 2019Dec 28, 2018Sep 28, 2018Jun 29, 2018Mar 30, 2018Dec 29, 2017Sep 29, 2017Jun 30, 2017Mar 31, 2017Dec 30, 2016Sep 30, 2016Jul 1, 2016Apr 1, 2016Jan 1, 2016Oct 2, 2015Jul 3, 2015Apr 3, 2015Jan 2, 2015
Selling, General, and Administrative Revenue 33.85M 37.13M 37.84M 45.80M 42.10M 45.83M 41.89M 41.04M 38.20M 41.79M 39.56M 36.27M 34.27M 35.38M 35.50M 35.04M 3.61M 33.90M 36.46M 37.66M 32.94M 33.14M 34.96M 35.14M 34.09M 36.78M 41.24M 42.62M 39.73M 39.72M 39.50M 37.51M 36.27M 37.63M 41.89M 33.51M 22.31M 24.10M 22.61M 24.85M
Selling, General, and Administrative Revenue Growth -8.81% -1.89% -17.38% +8.79% -8.13% +9.41% +2.07% +7.44% -8.59% +5.63% +9.08% +5.83% -3.14% -0.35% +1.33% +870.82% -89.35% -7.01% -3.20% +14.35% -0.63% -5.19% -0.53% +3.08% -7.31% -10.81% -3.24% +7.26% +0.02% +0.57% +5.30% +3.43% -3.62% -10.17% +25.01% +50.21% -7.45% +6.61% -9.01% n/a
Research and Development Revenue 11.92M 16.10M 15.75M 13.26M 14.54M 16.88M 19.09M 13.84M 16.12M 14.87M 16.08M 12.74M 12.05M 13.74M 13.46M 10.59M 11.89M 12.75M 13.24M 11.81M 11.73M 11.40M 11.60M 10.16M 12.23M 12.94M 14.54M 15.34M 13.61M 12.89M 13.41M 12.64M 11.41M 13.64M 17.31M 13.09M 14.30M 13.06M 12.54M 9.88M
Research and Development Revenue Growth -25.96% +2.23% +18.83% -8.82% -13.88% -11.57% +37.94% -14.15% +8.42% -7.54% +26.28% +5.69% -12.29% +2.06% +27.12% -10.96% -6.70% -3.74% +12.13% +0.68% +2.92% -1.72% +14.14% -16.96% -5.42% -11.03% -5.23% +12.74% +5.57% -3.89% +6.07% +10.79% -16.33% -21.18% +32.23% -8.47% +9.46% +4.13% +26.94% n/a